COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination.
作者信息
Tsalouchos Aris, Rossolini Gian Maria, Maggi Laura, Mazzoni Alessio, Annunziato Francesco, Dattolo Pietro Claudio
机构信息
Department of Medicine, Division of Nephrology, Santa Maria Annunziata Hospital, Florence, Italy.
Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
出版信息
Transpl Infect Dis. 2021 Aug;23(4):e13649. doi: 10.1111/tid.13649. Epub 2021 Jun 13.
Abstract
摘要
相似文献
1
COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination.基于mRNA的SARS-CoV-2疫苗接种后肾移植受者发生的新型冠状病毒肺炎
Transpl Infect Dis. 2021 Aug;23(4):e13649. doi: 10.1111/tid.13649. Epub 2021 Jun 13.
2
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.肾移植受者首次接种mRNA新冠疫苗后抗SARS-CoV-2抗体反应较弱。
Kidney Int. 2021 Jun;99(6):1487-1489. doi: 10.1016/j.kint.2021.03.014. Epub 2021 Mar 26.
3
A case of severe COVID-19 despite full vaccination with mRNA-1273 SARS-CoV-2 vaccine (Moderna) in a kidney transplant recipient.一名肾移植受者尽管已全程接种mRNA-1273新冠病毒疫苗（Moderna），仍感染了重症新冠病毒。
Transpl Infect Dis. 2021 Oct;23(5):e13710. doi: 10.1111/tid.13710. Epub 2021 Aug 16.
4
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.接受2剂mRNA-1273新型冠状病毒疫苗的肾移植受者中免疫接种率较低。
Kidney Int. 2021 Jun;99(6):1498-1500. doi: 10.1016/j.kint.2021.04.005. Epub 2021 Apr 20.
5
Protection against SARS-CoV-2 Variants with COVID-19 Vaccination in Kidney Transplant Recipients.肾移植受者接种新冠疫苗对SARS-CoV-2变异株的防护作用
Clin J Am Soc Nephrol. 2022 Jan;17(1):3-5. doi: 10.2215/CJN.14881121. Epub 2021 Dec 22.
6
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
7
Mortality Due to COVID-19 in Renal Transplant Recipients, Related to Variants of SARS-CoV-2 and Vaccination in Mexico.墨西哥与 SARS-CoV-2 变异株和疫苗接种相关的肾移植受者 COVID-19 死亡率。
Transplant Proc. 2022 Jul-Aug;54(6):1434-1438. doi: 10.1016/j.transproceed.2022.05.010. Epub 2022 Jun 1.
8
Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination.肾移植受者在接种第三剂新冠疫苗后，新冠病毒2型免疫球蛋白G抗体产生的动力学延迟
Clin Exp Nephrol. 2023 Jan;27(1):98-99. doi: 10.1007/s10157-022-02261-6. Epub 2022 Aug 5.
9
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.血清学反应和抗 SARS-CoV-2 疫苗接种的临床保护作用，以及免疫抑制药物在一组肾移植患者中的作用。
Viruses. 2022 Sep 2;14(9):1951. doi: 10.3390/v14091951.
10
Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.一名肝移植受者接种基于mRNA的SARS-CoV-2疫苗后的肝损伤
Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101743. doi: 10.1016/j.clinre.2021.101743. Epub 2021 Jun 16.
引用本文的文献
1
COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients.接种疫苗的肾移植受者中的新冠病毒突破性感染
Vaccines (Basel). 2022 Nov 11;10(11):1911. doi: 10.3390/vaccines10111911.
2
Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring.用简单抗体和干扰素γ释放试验细胞监测评估肾移植受者对两剂 mRNA COVID-19 疫苗的阴性免疫反应。
Am J Transplant. 2022 Mar;22(3):786-800. doi: 10.1111/ajt.16854. Epub 2021 Oct 7.
3
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept.肾移植受者接受贝利尤单抗治疗后，对 3 剂 mRNA 疫苗的抗体反应较弱。
Am J Transplant. 2021 Dec;21(12):4043-4051. doi: 10.1111/ajt.16814. Epub 2021 Sep 12.
本文引用的文献
1
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
2
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
3
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
4
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.通过 SARS-CoV-2 刺突蛋白变体逃避中和抗体。
Elife. 2020 Oct 28;9:e61312. doi: 10.7554/eLife.61312.
Zotero 插件